REDOX INC has a total of 17 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 1996. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets computer technology, digital networks and pharmaceuticals are SHENZHEN QIANHAI ANYCHECK INFORMATION TECHNOLOGY COMPANY, NANJING YIDUYUN MEDICAL TECH CO LTD and MOBILE HEARTBEAT LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Digital networks | |
#3 | Pharmaceuticals | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Healthcare informatics | |
#2 | Electric digital data processing | |
#3 | Digital information transmission | |
#4 | Medical preparations | |
#5 | Water treatment |
# | Name | Total Patents |
---|---|---|
#1 | Patel Nijay | 9 |
#2 | Tobin-Campbell Christopher | 9 |
#3 | Kitson Andrew | 9 |
#4 | Lloyd James | 9 |
#5 | Hatt Nicholas | 6 |
#6 | Haik George M Jr | 5 |
#7 | Hatt Nick | 3 |
#8 | Haik Jr George M | 1 |
#9 | Rego Blake | 1 |
#10 | Palmer Brandon | 1 |
Publication | Filing date | Title |
---|---|---|
US2020152337A1 | Systems and methods to organize the flow and processing of queued messages that have been received from healthcare entities | |
US2018101646A1 | Systems and methods for translating messages between a healthcare entity and a vendor entity | |
US2018101647A1 | Systems and methods for translating messages between a healthcare entity and a vendor entity | |
WO2014103083A1 | Electrolyzed water conforming to standards for water used in soft-drink manufacturing, and method for manufacturing said electrolyzed water | |
WO9851260A2 | Use of d-arginine and/or l-arginine to protect the amino groups of biological substances from damage, inactivation, or modification by toxic carbonyls and/or dicarbonyls | |
WO9717081A1 | Use of d-arginine and/or l-arginine to remove or block toxic carbonyls and/or dicarbonyls |